|
US7214686B2
(en)
|
1997-06-30 |
2007-05-08 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
|
GB9923078D0
(en)
*
|
1999-09-29 |
1999-12-01 |
Phytopharm Plc |
Sapogenin derivatives and their use
|
|
US8188043B2
(en)
|
1999-07-28 |
2012-05-29 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Nicotine in therapeutic angiogenesis and vasculogenesis
|
|
US6380224B1
(en)
*
|
1999-07-28 |
2002-04-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
|
|
IL150374A0
(en)
|
1999-12-23 |
2002-12-01 |
Neurochem Inc |
Compounds and methods for modulating cerebral amyloid angiopathy
|
|
JP2001261652A
(ja)
*
|
2000-03-21 |
2001-09-26 |
Suntory Ltd |
二置換イミノヘテロサイクリック化合物
|
|
EP1269201A1
(en)
*
|
2000-03-29 |
2003-01-02 |
Synaptica Limited |
Alpha 7 nicotinic receptor screening assays
|
|
WO2001089453A2
(en)
*
|
2000-05-19 |
2001-11-29 |
Wayne State University |
Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential cns receptor activity and behavior
|
|
US20030092613A1
(en)
*
|
2000-08-14 |
2003-05-15 |
Lee Daniel H. S. |
Alpha7 nicotinic receptor peptides as ligands for beta amyloid peptides
|
|
HUP0402289A2
(hu)
|
2001-10-02 |
2005-02-28 |
Pharmacia & Upjohn Company |
Gyógyhatású azabiciklusos csoporttal helyettesített kondenzált heteroaril-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
|
|
US6951868B2
(en)
|
2001-11-09 |
2005-10-04 |
Pfizer Inc. |
Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
|
|
EP1463481A4
(en)
|
2001-12-14 |
2008-06-25 |
Targacept Inc |
METHOD AND COMPOSITIONS FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM
|
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
|
US7045534B2
(en)
*
|
2002-02-12 |
2006-05-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of reducing angiogenesis
|
|
AU2003217275A1
(en)
*
|
2002-02-19 |
2003-09-09 |
Pharmacia And Upjohn Company |
Azabicyclic compounds for the treatment of disease
|
|
JP2005523288A
(ja)
*
|
2002-02-19 |
2005-08-04 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
疾病治療用の縮合した二環式−ｎ−架橋−複素環式芳香族カルボキサミド
|
|
JP2006501246A
(ja)
|
2002-08-30 |
2006-01-12 |
メモリー・ファーマシューティカルズ・コーポレイション |
神経変性疾患の治療において有用なアナバセイン誘導体
|
|
MXPA05003317A
(es)
|
2002-09-25 |
2005-07-05 |
Memory Pharm Corp |
Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos.
|
|
WO2004039815A2
(en)
*
|
2002-11-01 |
2004-05-13 |
Pharmacia & Upjohn Company Llc |
Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases
|
|
WO2004052365A2
(en)
*
|
2002-12-06 |
2004-06-24 |
North Shore-Long Island Jewish Research Institute |
Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
|
|
US7238715B2
(en)
*
|
2002-12-06 |
2007-07-03 |
The Feinstein Institute For Medical Research |
Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
WO2004074973A2
(en)
*
|
2003-02-19 |
2004-09-02 |
Balin Advertising Ltd. |
A system for providing private offers to customers of web sites
|
|
EP1635823A1
(en)
*
|
2003-05-20 |
2006-03-22 |
TransTech Pharma Inc. |
Rage antagonists as agents to reverse amyloidosis and diseases associated therewith
|
|
WO2005013910A2
(en)
*
|
2003-08-07 |
2005-02-17 |
University Of South Florida |
Cholinergic modulation of microglial activation via alpha-7 nicotinic receptors
|
|
AU2004282201A1
(en)
|
2003-10-15 |
2005-04-28 |
Targacept, Inc. |
Azabicycyclic compounds for relieving pain and treating central nervous system disorders
|
|
EP1541547A1
(en)
|
2003-12-11 |
2005-06-15 |
Newron Pharmaceuticals S.p.A. |
Hydroxylamine derivatives
|
|
US20050170360A1
(en)
*
|
2004-01-30 |
2005-08-04 |
Papke Roger L. |
Variant neuronal nicotinic alpha-7 receptor and methods of use
|
|
DE102004014841B4
(de)
*
|
2004-03-24 |
2006-07-06 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
|
|
NZ550534A
(en)
|
2004-03-25 |
2009-07-31 |
Memory Pharm Corp |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
|
US7678823B2
(en)
|
2004-10-04 |
2010-03-16 |
Myriad Pharmaceticals, Inc. |
Compounds for alzheimer's disease
|
|
US9216966B2
(en)
|
2004-10-04 |
2015-12-22 |
John Manfredi |
Compounds for Alzheimer's disease
|
|
BRPI0614874A2
(pt)
|
2005-08-22 |
2011-04-19 |
Targacept Inc |
diazatricicloalcanos substituìdos com heteroarila, métodos para sua preparação e uso dos mesmos
|
|
KR20080064956A
(ko)
*
|
2005-09-27 |
2008-07-10 |
미리어드 제네틱스, 인크. |
치료학적 화합물로서의 피롤 유도체
|
|
US8316104B2
(en)
|
2005-11-15 |
2012-11-20 |
California Institute Of Technology |
Method and apparatus for collaborative system
|
|
RU2432362C2
(ru)
|
2005-11-30 |
2011-10-27 |
Эбботт Лэборетриз |
Моноклональные антитела и их применения
|
|
PL2289909T3
(pl)
|
2005-11-30 |
2015-04-30 |
Abbvie Inc |
Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał
|
|
CA2633655A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Comentis, Inc. |
Topical mecamylamine formulations for ocular administration and uses therof
|
|
WO2007149392A1
(en)
*
|
2006-06-16 |
2007-12-27 |
University Of Kentucky |
Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
|
|
FR2905009A1
(fr)
*
|
2006-08-18 |
2008-02-22 |
Servier Lab |
Methode de criblage de composes aux proprietes anti-amyloide
|
|
CA2662870A1
(en)
*
|
2006-09-07 |
2008-03-13 |
Myriad Genetics, Inc. |
Therapeutic compounds for diseases and disorders
|
|
US8314119B2
(en)
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
TW200901974A
(en)
|
2007-01-16 |
2009-01-16 |
Wyeth Corp |
Compounds, compositions, and methods of making and using them
|
|
EP2124952A2
(en)
|
2007-02-27 |
2009-12-02 |
Abbott GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
|
DK2217597T3
(da)
|
2007-10-01 |
2011-06-20 |
Comentis Inc |
Quinuclidin-4-ylmethyl-1h-indol-3-carboxylatderivater som alpha-7-nicotin-acetylcholin-receptor-ligander til behandling af Alzheimers sygdom
|
|
JP2011511845A
(ja)
|
2008-02-13 |
2011-04-14 |
ターガセプト，インコーポレイテッド |
アルファ７（α７）ニコチン作動薬と抗精神病薬との組合せ物
|
|
RU2372355C1
(ru)
*
|
2008-06-27 |
2009-11-10 |
Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН |
Пептид, обладающий защитным действием против болезни альцгеймера
|
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
|
ES2467923T3
(es)
|
2009-09-30 |
2014-06-13 |
Transtech Pharma, Llc |
Derivados de imidazol substituidos para el tratamiento de la enfermedad de Alzheimer
|
|
ES2684475T3
(es)
|
2010-04-15 |
2018-10-03 |
Abbvie Inc. |
Proteínas que se unen a beta amiloide
|
|
DE102010020553A1
(de)
|
2010-05-14 |
2011-11-17 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 8-Alkoxy-2-aminotetralin-Derivate und ihre Verwendung
|
|
AR081402A1
(es)
|
2010-05-17 |
2012-08-29 |
Envivo Pharmaceuticals Inc |
Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il) benzo(b)tiofeno-2-carboxamida monohidrato
|
|
CN103298833B
(zh)
|
2010-08-14 |
2015-12-16 |
Abbvie公司 |
β淀粉样蛋白结合蛋白
|
|
CN103180321A
(zh)
|
2010-09-23 |
2013-06-26 |
Abbvie公司 |
氮杂金刚烷衍生物的一水合物
|
|
FR2966827B1
(fr)
|
2010-10-27 |
2014-08-22 |
Kimonella Ventures Ltd |
Compose peptidique utile pour l'inhibition de la formation de plaques amyloides
|
|
JP5850374B2
(ja)
*
|
2012-01-27 |
2016-02-03 |
パナソニックヘルスケア株式会社 |
アルツハイマー病の診断補助方法、及び診断システム
|
|
CA2872005A1
(en)
|
2012-05-08 |
2013-11-14 |
Forum Pharmaceuticals, Inc. |
Methods of maintaining, treating or improving cognitive function
|
|
ES2716049T3
(es)
*
|
2012-07-13 |
2019-06-07 |
Pain Therapeutics Inc |
Un método para inhibir la fosforilación de tau
|
|
JP6566867B2
(ja)
*
|
2012-07-13 |
2019-08-28 |
ペイン セラピューティクス インコーポレイテッド |
生きている患者でのアルツハイマー病アッセイ
|
|
ES2603262T3
(es)
|
2012-07-20 |
2017-02-24 |
Bayer Pharma Aktiengesellschaft |
Ácidos aminoindano-carboxílicos y aminotetralin-carboxílicos sustituidos y su uso
|
|
KR102137517B1
(ko)
|
2012-07-20 |
2020-07-24 |
바이엘 파마 악티엔게젤샤프트 |
신규 5-아미노테트라히드로퀴놀린-2-카르복실산 및 그의 용도
|
|
US9717710B2
(en)
|
2012-10-05 |
2017-08-01 |
Vtv Therapeutics Llc |
Treatment of mild and moderate Alzheimer's disease
|
|
GB201303507D0
(en)
*
|
2013-02-27 |
2013-04-10 |
Hollfelder Florian |
Assays
|
|
US20170166561A1
(en)
|
2014-07-11 |
2017-06-15 |
Alpharmagen, Llc |
Quinuclidine compounds for modulating alpha7-nicotinic acetylcholine receptor activity
|
|
US9724340B2
(en)
|
2015-07-31 |
2017-08-08 |
Attenua, Inc. |
Antitussive compositions and methods
|
|
WO2018067662A1
(en)
*
|
2016-10-04 |
2018-04-12 |
University Of Miami |
Protein amyloidogenesis and related methods
|
|
WO2019084365A1
(en)
*
|
2017-10-27 |
2019-05-02 |
St. Jude Children's Research Hospital, Inc. |
METHODS AND FORMULATIONS FOR THE TREATMENT OF SPINOBULAR MUSCLE ATROPHY
|
|
WO2019190822A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
WO2019190823A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chlorophenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
JP7464591B2
(ja)
|
2018-10-10 |
2024-04-09 |
ブイティーブイ・セラピューティクス・エルエルシー |
［３－（４－｛２－ブチル－１－［４－（４－クロロ－フェノキシ）－フェニル］－１ｈ－イミダゾール－４－イル｝－フェノキシ）－プロピル］－ジエチル－アミンの代謝産物
|
|
CU24626B1
(es)
|
2019-12-26 |
2022-11-07 |
Centro Nac De Biopreparados |
Composición farmacéutica a base de proteínas con actividad neuroprotectora, inmunomoduladora, antiinflamatoria y antimicrobiana
|
|
CN118765199A
(zh)
|
2021-12-29 |
2024-10-11 |
拜耳股份公司 |
心肺病症的治疗
|
|
TW202342012A
(zh)
|
2021-12-29 |
2023-11-01 |
德商拜耳廠股份有限公司 |
製備用作醫藥活性化合物的（５ｓ）－｛［２－（４－羧基苯基）乙基］［２－（２－｛［３－氯－４＇－（三氟甲基）聯苯－４－基］甲氧基｝苯基）乙基］胺基｝－５，６，７，８－四氫喹啉－２－羧酸及其結晶形式之方法
|